871 results on '"Lepage C"'
Search Results
2. Annual cycle of Whitewinged Scoters (Melanitta fusca)in eastern North America: migratory phenology, population delineation, and connectivity
3. Influence of Molecular Status on Recurrence Site in Patients Treated for a Stage III Colon Cancer: a Post Hoc Analysis of the PETACC-8 Trial
4. Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial
5. Identification of resources and skills developed by partners of patients with advanced colon cancer: a qualitative study
6. Apport de la volumétrie au rajeunissement facial. Partie 1 : greffe adipocytaire
7. Apport de la volumétrie au rajeunissement facial. Partie 2 : produits de comblement
8. Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort
9. Adjuvant FOLFOX +/− cetuximab in fullRAS andBRAF wildtype stage III colon cancer patients
10. Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers: A Phase II Multicenter Randomized Controlled Trial (PRODIGE 22)
11. Chimiothérapie par oxaliplatine normalisée à la quantité de masse maigre pour des cancers du côlon de stade III traités en adjuvant : impact sur les neurotoxicités à partir d’une étude randomisée multicentrique de phase II (LEANOX)
12. Sporadic non-functional neuroendocrine pancreatic incidentalomas (NF-NEI) ≤ 2 cm: risk of progression over 3 years. Results of the prospective multicenter French national study IPANEMA
13. The multidisciplinary management of gastro-oesophageal junction tumours: European Society of Digestive Oncology (ESDO): Expert discussion and report from the 16th ESMO World Congress on Gastrointestinal Cancer, Barcelona
14. Ipsilateral breast cancer recurrence after Deep Inferior Epigastric Perforator (DIEP) flap reconstruction: Incidence and radiological presentation
15. Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02)
16. Mise en place d’une activité de reconstruction microchirurgicale du sein par tissus autologues. Évolution sur 20 ans et revue de 1138 cas
17. La part positionnelle de la personne polyhandicapée en grande dépendance
18. Épidémiologie des tumeurs neuroendocrines intestinales
19. Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset
20. Toxicités cutanées et efficacité de l’enfortumab vedotin. Expérience monocentrique en vie réelle
21. Comment différencier un ‘vrai’ d’un ‘faux’ VIPome : étude nationale multicentrique du GTE-ENDOCAN-RENATEN avec test d’interférence biologique
22. LBA23 Avelumab versus standard second-line treatment chemotherapy in metastatic colorectal cancer (mCRC) patients with microsatellite instability (MSI): The SAMCO-PRODIGE 54 randomised phase II trial
23. LBA28 Prognostic effect of imaging and CEA follow-up in resected colorectal cancer (CRC): Final results and relapse free survival (RFS) - PRODIGE 13 a FFCD phase III trial
24. Author's reply: “Management of anal squamous cell carcinoma and its recurrences”
25. 321P A comprehensive predicting model of recurrence in stage III colon cancer from PETACC-8 trial
26. 502O Pembrolizumab in combination with CAPOX and bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: Preliminary results of FFCD 1703 POCHI trial
27. 1447P Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI-PRODIGE 62): A FFCD multicenter, randomized, phase II study
28. 594P Genetic and transcriptomic analyses of Early-Onset Colon Cancer (EOCC): A post-hoc analysis of 2973 patients (pts) from two adjuvant randomized trials
29. 572P Tolerance of adjuvant chemotherapy in older patients after resection of stage III colon adenocarcinoma from PRODIGE 34 – FFCD 1402 - ADAGE randomized phase III trial
30. 507O Impact of lean body mass-based oxaliplatin dosage on neurotoxicity in adjuvant treatment of stage III colorectal cancer: Final results of the phase II randomized multicenter LEANOX trial
31. MPI Parallelization of Unstructured Mesh Adaptation
32. Lichenoid eruption during antiPD-L1 immunotherapy with avelumab in metastatic colorectal cancer
33. Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995–2002
34. Diminution significative des volumes de drainage postopératoires en reconstruction mammaire différée par lambeau libre DIEP par utilisation de colle de fibrine
35. OC-0270 Final results of the French national cohort ANABASE : treatment and outcome in anal cancer
36. Cancer du côlon : bilan et surveillance
37. Economic Theory of Renewable Resource Management: A Multi-agent System Approach
38. Analyse médico-économique du lambeau libre de DIEP en reconstruction mammaire
39. Surveillance of colorectal cancers following curative-intent surgery: "Whatever the cost?"
40. Non-Pharmaceutical Interventions for Self-Regulatory Failures in Adolescents Suffering from Externalizing Symptoms: A Scoping Review
41. 391MO Impact of diabetes and metformin use on recurrence and outcome in early colon cancer (CC) patients: A pooled analysis of 3 adjuvant trials
42. LBA41 Nivolumab (nivo) ± ipilimumab (ipi) in pre-treated patients with advanced, refractory pulmonary or gastroenteropancreatic poorly differentiated neuroendocrine tumors (NECs) (GCO-001 NIPINEC)
43. Positive association between cognitive ability and cortical thickness in a representative US sample of healthy 6 to 18 year-olds
44. Protective effects of a cathepsin K inhibitor, SB-553484, in the canine partial medial meniscectomy model of osteoarthritis
45. PH-0113 Anti-Epidermal Growth Factor Receptor Therapy in combination with Chemoradiotherapy for the Treatment of Locally Advanced Anal Canal Carcinoma: Results of a Phase II Study with Panitumumab (FFCD 0904)
46. A collaborative resource platform for non-human primate neuroimaging
47. Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses.
48. 731P REWENEC: REal-World Evidence in NEC provides a reliable external control arm to avoid randomization for second-line clinical trials - A post hoc proof of concept analysis with the randomized phase II BEVANEC study
49. LBA77 5-fluorouracil and oxaliplatin with or without docetaxel in the first-line treatment of HER2 negative locally advanced (LA) unresectable or metastatic gastric or gastro-esophageal junction (GEJ) adenocarcinoma (GASTFOX-PRODIGE 51): A randomized phase III trial sponsored by the FFCD
50. 629P First results of the french prospective cohort of colorectal cancers with microsatellite instability (COLOMIN2)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.